Logo image of OBEL.BR

ORANGE BELGIUM (OBEL.BR) Stock Fundamental Analysis

EBR:OBEL - Euronext Brussels - BE0003735496 - Common Stock - Currency: EUR

16.5  -0.2 (-1.2%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to OBEL. OBEL was compared to 6 industry peers in the Wireless Telecommunication Services industry. While OBEL is still in line with the averages on profitability rating, there are concerns on its financial health. OBEL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

OBEL had positive earnings in the past year.
In the past year OBEL had a positive cash flow from operations.
OBEL had positive earnings in each of the past 5 years.
In the past 5 years OBEL always reported a positive cash flow from operatings.
OBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFOBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

The Return On Assets of OBEL (0.54%) is worse than 66.67% of its industry peers.
The Return On Equity of OBEL (2.31%) is comparable to the rest of the industry.
With a decent Return On Invested Capital value of 3.15%, OBEL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
OBEL had an Average Return On Invested Capital over the past 3 years of 4.46%. This is in line with the industry average of 6.11%.
Industry RankSector Rank
ROA 0.54%
ROE 2.31%
ROIC 3.15%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
OBEL.BR Yearly ROA, ROE, ROICOBEL.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 1.11%, OBEL is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
OBEL's Profit Margin has declined in the last couple of years.
OBEL has a Operating Margin (6.95%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of OBEL has grown nicely.
Looking at the Gross Margin, with a value of 67.46%, OBEL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of OBEL has grown nicely.
Industry RankSector Rank
OM 6.95%
PM (TTM) 1.11%
GM 67.46%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
OBEL.BR Yearly Profit, Operating, Gross MarginsOBEL.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1

2. Health

2.1 Basic Checks

OBEL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
OBEL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for OBEL has been increased compared to 5 years ago.
OBEL has a better debt/assets ratio than last year.
OBEL.BR Yearly Shares OutstandingOBEL.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OBEL.BR Yearly Total Debt VS Total AssetsOBEL.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

OBEL has an Altman-Z score of 0.96. This is a bad value and indicates that OBEL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.96, OBEL is doing worse than 66.67% of the companies in the same industry.
OBEL has a debt to FCF ratio of 20.08. This is a negative value and a sign of low solvency as OBEL would need 20.08 years to pay back of all of its debts.
OBEL has a Debt to FCF ratio of 20.08. This is in the better half of the industry: OBEL outperforms 66.67% of its industry peers.
A Debt/Equity ratio of 2.12 is on the high side and indicates that OBEL has dependencies on debt financing.
OBEL has a worse Debt to Equity ratio (2.12) than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.12
Debt/FCF 20.08
Altman-Z 0.96
ROIC/WACC0.62
WACC5.06%
OBEL.BR Yearly LT Debt VS Equity VS FCFOBEL.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

OBEL has a Current Ratio of 0.61. This is a bad value and indicates that OBEL is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.61, OBEL is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
OBEL has a Quick Ratio of 0.61. This is a bad value and indicates that OBEL is not financially healthy enough and could expect problems in meeting its short term obligations.
OBEL's Quick ratio of 0.56 is on the low side compared to the rest of the industry. OBEL is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.56
OBEL.BR Yearly Current Assets VS Current LiabilitesOBEL.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48642.86% over the past year.
OBEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.64% yearly.
The Revenue has grown by 13.96% in the past year. This is quite good.
Measured over the past years, OBEL shows a quite strong growth in Revenue. The Revenue has been growing by 8.26% on average per year.
EPS 1Y (TTM)48642.86%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%118.05%
Revenue 1Y (TTM)13.96%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%0.71%

3.2 Future

Based on estimates for the next years, OBEL will show a very strong growth in Earnings Per Share. The EPS will grow by 33.42% on average per year.
OBEL is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -10.97% yearly.
EPS Next Y55.47%
EPS Next 2Y40.71%
EPS Next 3Y33.42%
EPS Next 5YN/A
Revenue Next Year1.17%
Revenue Next 2Y1.06%
Revenue Next 3Y0.55%
Revenue Next 5Y-10.97%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OBEL.BR Yearly Revenue VS EstimatesOBEL.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
OBEL.BR Yearly EPS VS EstimatesOBEL.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

OBEL is valuated quite expensively with a Price/Earnings ratio of 48.53.
Compared to the rest of the industry, the Price/Earnings ratio of OBEL indicates a slightly more expensive valuation: OBEL is more expensive than 66.67% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. OBEL is valued rather expensively when compared to this.
With a Price/Forward Earnings ratio of 20.61, OBEL is valued on the expensive side.
OBEL's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. OBEL is more expensive than 66.67% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of OBEL to the average of the S&P500 Index (22.19), we can say OBEL is valued inline with the index average.
Industry RankSector Rank
PE 48.53
Fwd PE 20.61
OBEL.BR Price Earnings VS Forward Price EarningsOBEL.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, OBEL is valued cheaper than 100.00% of the companies in the same industry.
OBEL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. OBEL is cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.42
EV/EBITDA 5.23
OBEL.BR Per share dataOBEL.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

OBEL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OBEL's earnings are expected to grow with 33.42% in the coming years.
PEG (NY)0.87
PEG (5Y)N/A
EPS Next 2Y40.71%
EPS Next 3Y33.42%

0

5. Dividend

5.1 Amount

OBEL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ORANGE BELGIUM

EBR:OBEL (6/19/2025, 7:00:00 PM)

16.5

-0.2 (-1.2%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)02-07 2025-02-07/amc
Earnings (Next)07-24 2025-07-24
Inst Owners5.2%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.11B
Analysts76
Price Target19.25 (16.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-57.8%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.84%
PT rev (3m)10.29%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)17.18%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.24%
Valuation
Industry RankSector Rank
PE 48.53
Fwd PE 20.61
P/S 0.56
P/FCF 10.42
P/OCF 2.21
P/B 1.16
P/tB N/A
EV/EBITDA 5.23
EPS(TTM)0.34
EY2.06%
EPS(NY)0.8
Fwd EY4.85%
FCF(TTM)1.58
FCFY9.6%
OCF(TTM)7.46
OCFY45.2%
SpS29.58
BVpS14.23
TBVpS-9.7
PEG (NY)0.87
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.54%
ROE 2.31%
ROCE 4.2%
ROIC 3.15%
ROICexc 3.21%
ROICexgc 6.38%
OM 6.95%
PM (TTM) 1.11%
GM 67.46%
FCFM 5.35%
ROA(3y)1.11%
ROA(5y)1.76%
ROE(3y)3.59%
ROE(5y)5.18%
ROIC(3y)4.46%
ROIC(5y)4.89%
ROICexc(3y)4.56%
ROICexc(5y)5.09%
ROICexgc(3y)11.41%
ROICexgc(5y)10.53%
ROCE(3y)6.22%
ROCE(5y)6.69%
ROICexcg growth 3Y-7.87%
ROICexcg growth 5Y2.19%
ROICexc growth 3Y-16.49%
ROICexc growth 5Y-3.51%
OM growth 3Y7.61%
OM growth 5Y9.59%
PM growth 3Y-27.48%
PM growth 5Y-15.2%
GM growth 3Y4.71%
GM growth 5Y4.35%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 2.12
Debt/FCF 20.08
Debt/EBITDA 3.33
Cap/Depr 83.78%
Cap/Sales 19.86%
Interest Coverage 1.31
Cash Conversion 82.24%
Profit Quality 481.9%
Current Ratio 0.61
Quick Ratio 0.56
Altman-Z 0.96
F-Score8
WACC5.06%
ROIC/WACC0.62
Cap/Depr(3y)156.85%
Cap/Depr(5y)119.41%
Cap/Sales(3y)34.82%
Cap/Sales(5y)26.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48642.86%
EPS 3Y-19.85%
EPS 5Y-9.64%
EPS Q2Q%118.05%
EPS Next Y55.47%
EPS Next 2Y40.71%
EPS Next 3Y33.42%
EPS Next 5YN/A
Revenue 1Y (TTM)13.96%
Revenue growth 3Y13.5%
Revenue growth 5Y8.26%
Sales Q2Q%0.71%
Revenue Next Year1.17%
Revenue Next 2Y1.06%
Revenue Next 3Y0.55%
Revenue Next 5Y-10.97%
EBIT growth 1Y12.13%
EBIT growth 3Y22.15%
EBIT growth 5Y18.64%
EBIT Next Year291.94%
EBIT Next 3Y57.64%
EBIT Next 5Y21.59%
FCF growth 1Y184.99%
FCF growth 3Y-9.07%
FCF growth 5Y-7.65%
OCF growth 1Y33.27%
OCF growth 3Y10.98%
OCF growth 5Y8.17%